Post-authorisation Safety (PAS) Observational Cohort Study to Quantify the Incidence and Comparative Safety of Selected Cardiovascular and Cerebrovascular Events in COPD Patients Using Inhaled UMEC/VI Combination or Inhaled UMEC versus Tiotropium (Study

Project: Other project

StatusActive
Effective start/end date12/7/1612/6/19

Funding

  • GlaxoSmithKline Pharmaceuticals: $2,307.69